// App-Quantinova.ai

5677 : Recurrent transcriptionally active ESR1 fusions render therapeutic vulnerabilities to kinase inhibition in advanced breast cancer

Researchers

Presenter

  • Xuxu Gou

Principal Investigators

  • Jonathan Lei

  • Beom-Jun Kim

  • Meenakshi Anurag

  • Sinem Seker

  • Saif Rehman

  • Adrian V. Lee

  • Kevin White

  • Michael Caldwell

  • Jonathan Ball

  • Dan R. Robinson

  • Matthew J. Ellis

Medical Centers

  • Baylor College of Medicine, Houston, TX

  • University of Cambridge, Cambridge, United Kingdom

  • University of Pittsburgh, Pittsburgh, PA

  • Tempus, Inc., Chicago, IL

  • University of Michigan, Ann Arbor, MI

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Estrogen Receptor 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved